Adicet Bio, Inc. (ACET)
Total Valuation
Adicet Bio has a market cap or net worth of $81.58 million. The enterprise value is -$79.88 million.
| Market Cap | 81.58M |
| Enterprise Value | -79.88M |
Important Dates
The last earnings date was Wednesday, November 8, 2023, after market close.
| Earnings Date | Nov 8, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
Adicet Bio has 43.16 million shares outstanding. The number of shares has increased by 3.21% in one year.
| Shares Outstanding | 43.16M |
| Shares Change (YoY) | +3.21% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 2.51% |
| Owned by Institutions (%) | 82.50% |
| Float | 29.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.40, with a Debt / Equity ratio of 0.11.
| Current Ratio | 9.40 |
| Quick Ratio | n/a |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,859.88 |
Financial Efficiency
Return on equity (ROE) is -57.70% and return on invested capital (ROIC) is -70.23%.
| Return on Equity (ROE) | -57.70% |
| Return on Assets (ROA) | -49.90% |
| Return on Capital (ROIC) | -70.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.08M |
| Employee Count | 132 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.89% in the last 52 weeks. The beta is 1.52, so Adicet Bio's price volatility has been higher than the market average.
| Beta (1Y) | 1.52 |
| 52-Week Price Change | -77.89% |
| 50-Day Moving Average | 1.36 |
| 200-Day Moving Average | 3.21 |
| Relative Strength Index (RSI) | 69.80 |
| Average Volume (30 Days) | 404,374 |
Short Selling Information
The latest short interest is 2.53 million, so 5.85% of the outstanding shares have been sold short.
| Short Interest | 2.53M |
| Short Previous Month | 3.12M |
| Short % of Shares Out | 5.85% |
| Short % of Float | 8.59% |
| Short Ratio (days to cover) | 6.33 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -152.04M |
| Pretax Income | -143.04M |
| Net Income | -143.04M |
| EBITDA | -134.72M |
| EBIT | -142.99M |
| Earnings Per Share (EPS) | -$3.35 |
Balance Sheet
The company has $183.26 million in cash and $21.80 million in debt, giving a net cash position of $161.46 million or $3.74 per share.
| Cash & Cash Equivalents | 183.26M |
| Total Debt | 21.80M |
| Net Cash | 161.46M |
| Net Cash Per Share | $3.74 |
| Equity / Book Value | 194.68M |
| Book Value Per Share | 4.51 |
| Working Capital | 166.12M |
Cash Flow
In the last 12 months, operating cash flow was -$89.07 million and capital expenditures -$10.82 million, giving a free cash flow of -$99.89 million.
| Operating Cash Flow | -89.07M |
| Capital Expenditures | -10.82M |
| Free Cash Flow | -99.89M |
| FCF Per Share | -$2.32 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Adicet Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -175.34% |
| FCF Yield | -122.44% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.21% |
| Shareholder Yield | -3.21% |
Analyst Forecast
The average price target for Adicet Bio is $15.67, which is 729.10% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.67 |
| Price Target Difference | 729.10% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 42.57% |
| EPS Growth Forecast (5Y) | -13.46% |
Stock Splits
The last stock split was on September 16, 2020. It was a reverse split with a ratio of 1:7.
| Last Split Date | Sep 16, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |